stoxline Quote Chart Rank Option Currency Glossary
  
LivaNova PLC (LIVN)
44.06  -0.01 (-0.02%)    05-09 16:00
Open: 44.19
High: 44.94
Volume: 1,063,416
  
Pre. Close: 44.07
Low: 43.89
Market Cap: 2,402(M)
Technical analysis
2025-05-10 10:03:53 AM
Short term     
Mid term     
Targets 6-month :  52.48 1-year :  61.3
Resists First :  44.93 Second :  52.48
Pivot price 37.98
Supports First :  37.23 Second :  32.47
MAs MA(5) :  40.61 MA(20) :  37.22
MA(100) :  43 MA(250) :  48.54
MACD MACD :  0.9 Signal :  -0.1
%K %D K(14,3) :  93.9 D(3) :  75.9
RSI RSI(14): 70.1
52-week High :  63.56 Low :  32.47
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ LIVN ] has closed below upper band by 0.4%. Bollinger Bands are 100.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 44.99 - 45.25 45.25 - 45.48
Low: 43.3 - 43.58 43.58 - 43.83
Close: 43.66 - 44.11 44.11 - 44.51
Company Description

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

Headline News

Thu, 08 May 2025
LivaNova (LIVN) Receives Price Target Boost from Baird | LIVN Stock News - GuruFocus

Thu, 08 May 2025
LivaNova PLC (LIVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances - Yahoo Finance

Thu, 08 May 2025
LivaNova PLC Reports Strong Q1 2025 Results - TipRanks

Wed, 07 May 2025
LivaNova: Q1 Earnings Snapshot - MySA

Wed, 07 May 2025
LivaNova PLC SEC 10-Q Report - TradingView

Wed, 07 May 2025
Will LivaNova's Growth And Innovation Drive Sustained Gains In 2025? - Nasdaq

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 55 (M)
Shares Float 51 (M)
Held by Insiders 0.3 (%)
Held by Institutions 104.1 (%)
Shares Short 1,800 (K)
Shares Short P.Month 1,630 (K)
Stock Financials
EPS -4.08
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 18.96
Profit Margin -17.5 %
Operating Margin 15.5 %
Return on Assets (ttm) 4.5 %
Return on Equity (ttm) -19.8 %
Qtrly Rev. Growth 7.4 %
Gross Profit (p.s.) 16.23
Sales Per Share 23.47
EBITDA (p.s.) 4.12
Qtrly Earnings Growth 0 %
Operating Cash Flow 197 (M)
Levered Free Cash Flow 782 (M)
Stock Valuations
PE Ratio -10.83
PEG Ratio 0
Price to Book value 2.32
Price to Sales 1.87
Price to Cash Flow 12.19
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android